New study monitors SPINRAZA's effect on movement in adults with spinal muscular atrophy
NCT ID NCT04159987
First seen Dec 08, 2025 · Last updated May 14, 2026 · Updated 23 times
Summary
This study follows 20 adults with spinal muscular atrophy (SMA) type II who are already taking SPINRAZA, a medication given via spinal injection. Researchers will measure changes in motor function, like sitting, standing, and arm movement, over 27 months. The goal is to see how well the drug maintains or improves movement in this group.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SPINAL MUSCULAR ATROPHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
APHP
Paris, Île-de-France Region, 94000, France
-
CHRU de Lille
Lille, Hauts-de-France, 59000, France
-
CHU de Lyon
Lyon, Auvergne-Rhône-Alpes, 69677, France
-
CHU de Montpellier
Montpellier, Occitanie, 34090, France
-
CHU de Nice
Nice, Provence-Alpes-Côte d'Azur Region, 06000, France
-
CHU de Toulouse
Toulouse, Occitanie, 31059, France
-
Hopital de la Timone - APHM
Marseille, Provence-Alpes-Côte d'Azur Region, 13005, France
Conditions
Explore the condition pages connected to this study.